250+ investors that invest in your industry and stage
Transportation
Gaming
Community
Proptech
FinTech
Biotech
Climate
Marketplace
Artificial intelligence
Energy
Hardware
Media (entertainment)
EdTech
Consumer
Health Care
Impact
Enterprise
Agriculture (agtech)
Sustainability
Venture Capital
Restaurants
Fashion
Real Estate
Retail
Infrastructure
Mobile Apps
Beauty
LGBT
Web3
Publishing
Clean Energy
Sporting Goods
Oil and Gas
B2B
Education
Organic Food
Big Data
Renewable Energy
Food and Beverage
Cryptocurrency
Finance
Video Games
Financial Services
Payments
Photography
Celebrity
Art
Medical
Digital Media
Music
Internet
Social Media
Manufacturing
Facebook
Franchise
Blockchain
Legal
Android
Social Impact
Mobile
Google
Construction
Sports
Local
eSports
Enterprise Software
Email
Wellness
Social Network
Hospitality
Travel
Fitness
Mobile Advertising
Cannabis
Recruiting
Platforms
Biotechnology
Medical Device
Wine And Spirits
Automotive
Crowdfunding
Social
CleanTech
InsurTech
SaaS
Software
Film
Theatre
Life Science
Non Profit
Qatar
New Zealand
United States
South Korea
Germany
Australia
India
United Kingdom
Ireland
Canada
Africa
Asia
LATAM
Europe
Oceania
Middle East
China
South Africa
Singapore
Brazil
Japan
Indonesia
Sri Lanka
Vietnam
Spain
Saudi Arabia
Argentina
Armenia
Austria
Bangladesh
Bahrain
Belarus
Bulgaria
Belgium
Bermuda
Chile
Cameroon
Switzerland
Colombia
Belize
Costa Rica
Denmark
Ecuador
Algeria
Czech Republic
Georgia
Estonia
Egypt
Ghana
Hong Kong
Ethiopia
Gibraltar
Faroe Islands
Greece
Finland
Croatia
France
Hungary
Barbados
Kuwait
Italy
Jersey
Israel
Lebanon
Cambodia
Kenya
Cayman Islands
Jordan
Lithuania
Liberia
Liechtenstein
Myanmar
Kazakhstan
Mali
Morocco
Norway
Malaysia
Mexico
Panama
Malta
Mauritius
Peru
Philippines
Nicaragua
Pakistan
Poland
Russian Federation
Romania
Sweden
Rwanda
Serbia
Seychelles
Turkey
Togo
Puerto Rico
Slovenia
Sierra Leone
San Marino
Senegal
Tunisia
Tanzania
Tajikistan
El Salvador
Uganda
Zambia
Uzbekistan
Thailand
Taiwan
Ukraine
Uruguay
Zimbabwe
Venezuela
Portugal
Azerbaijan
Bahamas
Guatemala
Iraq
Iceland
Namibia
Nigeria
United Arab Emirates
Honduras
Bolivia
Isle of Man
Luxembourg
Cyprus
Latvia
Oman
Angel investors
VC Funds
All investors
Download Find emails Save list

Top 35 Medical VC (Venture Capital) Funds in Finland in October 2023

A list of 35 VC (Venture Capital) funds that invest in Medical startups based in Finland. We rank investors based on the number of investments they made in Medical companies from Finland. We update this investor list every month.

Top 35 Medical VC (Venture Capital) Funds in Finland in October 2023

Investor Medical Finland investments
Finnvera Venture Capital 7
Voima Ventures 5
Lifeline Ventures 5
Business Finland 5
Reaktor Ventures 3
Icebreaker.vc 3
Butterfly Ventures 3
Karolinska 2
Innovestor 2
Metsola Ventures 2
Vesalius Biocapital Partners 2
Novo Holdings 2
Maki.vc 2
Inventure 2
Hadean Ventures 1
Way to Wellville 1
Inveni Capital 1
Capricorn Partners 1
Sunstone Life Science Ventures 1
MVM Life Science Partners 1
Cor Group 1
High-Tech Grunderfonds 1
M Ventures 1
Novartis Venture Fund 1
Tesi 1
Springvest 1
Nuard Ventures 1
Metaplanet Holdings 1
Noaber 1
Visionplus 1
SHS Capital 1
Debiopharm Innovation Fund 1
Athensmed 1
Ascend Capital Partners 1
Cascara Ventures 1

Get 300+ niche investors in 2 minutes.

Find who invests in your industry, stage, and region in our 200k+ database with AI-powered matching.

Find investors — It's Free!

Trusted by 21,000+ founders from:

Y Combinator Techstars Antler Pioneer On Deck
Investor list
Finnvera Venture Capital
VC Fund · Kuopio, Eastern Finland, Finland

Finnvera makes direct investments in early-stage enterprises through Seed Fund Vera Ltd. Finnvera's goal is to cover shortcomings existing on the market between product development funding and private equity investments. Finnvera does not compete with private financiers; instead, it strives to supplement the financial market.Finnvera'sinvestments enable, start and accelerate growth and internationalisation among investment targets. Enterprises are developed to make them attractive targets for further financing by other investors and industrial actors. Investments are made in technology enterprises at an early stage and in technology-intensive or innovative service enterprises that have potential for developing into international growth enterprises.Finnvera is also known as a specialised financing company owned by the State of Finland. It provides its clients with loans, guarantees, venture capital investments and export credit guarantees.

Show more...

Investment focus

  • Software, Health Care, Information Technology
  • Seed, Funding Round, Series A
  • Finland, United States, Switzerland

Portfolio highlights

  • Enfuce — Enfuce is a cloud-based financial services provider that specializes in card issuing and payment processing services. It helps banks, fintech, and financial institutions become and remain fully PSD2 compliant, and helps them give third-party service providers access to digital accounts.The company was founded in 2016 and is headquartered inEspoo, Finland.
  • Nordcloud — Nordcloud is a European leader in public cloud infrastructure solutions and cloud-native application services. Since 2011 we have completed more than 500 deployments to help our enterprise customers gain the maximum benefits of the cloud, including security, agility, scalability and overall cost-savings.
  • Aurealis Pharma — Multi-target cell and gene therapies for unmet medical needs. Developing therapies for chronic wounds, cancer and inflammatory diseases.
Show more investments...

Voima Ventures
VC Fund · Helsinki, Southern Finland, Finland · 9 investments in the past 12 months

Voima Ventures’ mission is to solve major global problems by combining science, entrepreneurship, and value adding capital. They shed light on the ideas and technology which require time and courage to build. Industry domains include bio and new materials, medical technologies and life sciences, imaging and optics, IoT and electronics, robotics,software & ICT and AI. In addition, Voima Ventures has invested in more than 30 deep tech startups, including companies like Solar Foods, Infinited Fiber Company, and Dispelix. Cornerstone investors are VTT Technical Research Centre of Finland and European Investment Fund (EIF), backed by Finnish private and institutional investors.

Show more...

Investment focus

  • Biotechnology, Health Care, Software
  • Seed, Pre-Seed, Funding Round
  • Finland, Norway, Sweden

Portfolio highlights

  • ÄIO — Innovative food technologies to replace palm oil, coconut oil and animal fats with sustainable and healthier alternatives.
  • Alba Health — Discover your baby's gut health & microbiome for the best start in life.
  • Quantagonia — Advanced quantum algorithms, for your most important business problems, delivering breakthrough performance on today's high-performance computers, with seamless migration for later use on quantum computers.
Show more investments...

Lifeline Ventures
VC Fund · Helsinki, Southern Finland, Finland · 9 investments in the past 12 months

Lifeline Ventures Oy is a venture capital firm specializing in startups, growth capital, and early stage investments. The firm seeks to invest in healthcare, games, web based and general high technology sectors. It seeks to invest in Finland with a few investments made outside Finland as well. The firm targets investing between €0.5 million ($0.66million) and €1 million ($1.32 million). It seeks make inception to Series A investments. Lifeline Ventures Oy was founded in November 2009 and is based in Helsinki, Finland.

Show more...

Investment focus

  • Software, Health Care, E-Commerce
  • Seed, Series A, Funding Round
  • Finland, United States, United Kingdom

Portfolio highlights

  • Metroc — Creating sales and marketing solutions for the construction & real-estate industry.
  • Measurlabs — We provide testing services for any material, product, or chemical, helping product developers and quality managers get the information they need about their products.
  • Steady Energy — Steady Energy aims to decarbonize the energy-intensive heating industry starting with residential and district heating.
Show more investments...

Business Finland
VC Fund · Helsinki, Southern Finland, Finland · 14 investments in the past 12 months

Business Finland finances business R&D projects and public research projects at universities, research institutes and universities of applied sciences. Read more about R&D and business funding.

Show more...

Investment focus

  • Software, Information Technology, SaaS
  • Seed, Grant, Funding Round
  • Finland, United States, United Kingdom

Portfolio highlights

  • Fixably — Fixably is the repair management solution to seamlessly connect all users, from the end customer to the technician, and all repair systems within your service business.
  • Valosan — Scale your international PR into any local market. With Valosan, you connect with PR specialists in local markets and pitch your story to real journalists
  • Vensum Power — Revolutionizing power conversion. More power in same package, less energy waste and low maintenance.
Show more investments...

Reaktor Ventures
VC Fund · Helsinki, Southern Finland, Finland

Reaktor Ventures has moved to the next phase by focusing its efforts to actively supporting current portfolio companies. This means that the fund has ended its investment period and is not investing into new companies. Between 2013 and 2018 we have invested into 42 different companies and one early stage fund. We will naturally keep makingfollow-up investments to current portfolio companies.

Show more...

Investment focus

  • Software, Internet, Health Care
  • Seed, Pre-Seed, Series A
  • Finland, Germany, United States

Portfolio highlights

  • Valpas — Valpas is the hygiene protocol that reassures your future guests and keeps your hotel clean from the most uncontrollable: bed bugs
  • Swappie — Buy refurbished iPhones at an affordable price - Swappie offers refurbished and cheap iPhones with a free 12-month Swappie warranty.
  • Videoly — The easiest way for online retailers to get hand-picked and automatically embedded product videos.
Show more investments...

Icebreaker.vc
VC Fund · Helsinki, Southern Finland, Finland · 11 investments in the past 12 months

Founded in 2016, Icebreaker has invested in over 50 fast-growing tech startups built by domain expert founders from companies like Rovio, Nordea, Pipedrive, Eniram, IBM and BCG. In addition to the fund, Icebreaker also runs a community of more than 1000 founders and pre-founders with 5+ years of relevant industry experience and the will to start,build or join strong tech companies.With the initial ticket sizes of €150k - 800K Icebreaker provides enough funding for companies to get to a position of strength and avoid post-accelerator limbo without having to resort to disreputable sources of capital and unfriendly deal terms.

Show more...

Investment focus

  • Software, Information Technology, Artificial Intelligence
  • Pre-Seed, Seed, Series A
  • Finland, Estonia, Sweden

Portfolio highlights

  • Aibidia — Discover the Aibidia TXM Platform and our digital transfer pricing applications, eliminating billions of euros in tax inefficiencies and risks.
  • Fixably — Fixably is the repair management solution to seamlessly connect all users, from the end customer to the technician, and all repair systems within your service business.
  • IPRally — Improve your invalidity, patentability and FTO searches. Easy-to-use patent search web application, powered by unique AI knowledge graph technology.
Show more investments...

Butterfly Ventures
VC Fund · Oulu, Oulu, Finland · 4 investments in the past 12 months

Butterfly Ventures is a seed-stage focused VC in the Nordics, investing in deep tech, hardware, and hardware interfacing software. The company prefers to get involved with companies early on; 80% of Butterfly Ventures portfolio companies don't have any revenue at the time of their entry. Butterfly Ventures was founded in 2012 and ever sincethen it has been one of the most active early stage VCs in the region. The company has offices in Oulu, Helsinki and Stockholm.

Show more...

Investment focus

  • Health Care, Software, Information Technology
  • Seed, Funding Round, Pre-Seed
  • Finland, Sweden, Norway

Portfolio highlights

  • Reactional Music — GESTRUMENT is the revolutionary gesture based instrument.
  • EmbeDL — Efficient Deep Learning for Embedded Systems
  • Retein — Aquammodate is a greentech company that produces highly pure water at minimum energy cost.
Show more investments...

Karolinska
VC Fund · Solna, Stockholms Lan, Sweden · 3 investments in the past 12 months

Karolinska Development aims to create value for patients, researchers, investors and society by developing innovations from world class science into products that can be sold or out-licensed with high returns. The business model is to: SELECT the most commercially attractive medical innovations; DEVELOP innovations to the stage where the greatestreturn on investment can be achieved; and COMMERCIALIZE the innovations through the sale of companies or out-licensing of products.Karolinska Development has developed a well-structured selection process to identify the most commercially attractive medical innovations screened by KIAB. Pharmaceutical development is a high-risk enterprise. In most cases, development projects fail because of side effects or insufficient efficacy. Successful selection of innovations is fundamental to Karolinska Development’s business model, which makes the inflow of new projects crucial. One key to success lies in selecting those innovations that can be developed from scientific findings to products and have significant commercial potential. To date, over 1,300 projects have been screened by KIAB.The portfolio companies are often founded together with the innovators and are initially operated as virtual companies with few or no employees. During the first six to twelve months, the companies normally have minimal fixed costs and technological development is outsourced.The innovator, who is often employed at an academic institution, normally participates as a board member and scientific advisor. The CEO of a portfolio company cooperates closely with a representative of Karolinska Development, who in most cases is also a board member of the company. The companies are capitalized to reach their next milestone, usually within a period of six to eighteen months. Development projects are continuously monitored, and those that do not meet their stipulated targets are discontinued. In the first three to four years, a portfolio company’s operating expenses are often limited to a few million Swedish kronor per year, which cover the cost of external studies and the salary of the staff. In subsequent years, Karolinska Development and other investors play an important role recruiting key expertise to the companiesKarolinska Development intends to realize value by exiting portfolio companies or through out-licensing of projects. Such transactions (especially out-licensing) are often structured as single upfront payments followed by payments based on predetermined milestones and royalties on sales. Although Karolinska Development has a flexible exit strategy, pharmaceutical products are, for two reasons, preferably exited at Phase II. First a successful Phase II study indicates that the pharmaceutical has an effect on patients, which is an important value-enhancing factor when negotiating out-licensing or sales. Secondly, finalizing product development and undertaking Phase III clinical trials frequently requires very large patient populations. In many cases this requires much greater resources than those available at Karolinska Development but these can be found in established pharmaceutical companies. Several licensing deals were closed in 2011 involving projects with a similar focus and development phase to Karolinska Development's projects.

Show more...

Investment focus

  • Biotechnology, Health Care, Pharmaceutical
  • Funding Round, Seed, Series A
  • Sweden, Denmark, United States

Portfolio highlights

  • Henlez — Henlez is a Danish startup company.
  • OssDsign AB — OssDsign was founded in May 2011 by Professor Håkan Engqvist, Dr Thomas Engstrand, Bo Qwarnstrom, Jonas Åberg, Uppsala University AB and other leading clinical, preclinical and materials researchers and engineers. The key people in the company are presented below. OssDsign has in addition developed a network of international experts in ClinicalAffairs, Regulatory and Business Development.
  • Modus Therapeutics — Modus Therapeutics is a Swedish drug development company developing sevuparin – a novel drug to treat people suffering from Sickle Cell Disease – a painful, inherited blood disorder affecting millions of people around the globe.
Show more investments...

Innovestor
VC Fund · Helsinki, Southern Finland, Finland · 2 investments in the past 12 months

Welcome to Innovestor! We are a Finnish investment company focusing on venture capital, corporate venturing services, and real estate.

Show more...

Investment focus

  • Software, Health Care, Manufacturing
  • Funding Round, Seed, Series A
  • Finland, Denmark, Sweden

Portfolio highlights

  • SynergyXR — SynergyXR is a no-code, cloud platform that lets companies design, onboard, sell, and support across all XR devices without writing a single line of code
  • HVR Cardio — HVR Cardio Transformative Mitral Valve Repair Solutions The Future of Mitral Valve Repair Our mission is to develop solutions for mitral valve interventions that are faster, easier to use, and less invasive without compromising clinical efficacy. About HVR Cardio Utilization of new technologies and less...
  • Teitur Trophics — Teitur Trophics is a biotech company developing circular peptides for neurodegenerative diseases. The company was founded in 2020 and is headquartered in Aarhus, Denmark.
Show more investments...

Metsola Ventures
VC Fund · Espoo, Southern Finland, Finland

Metsola Ventures

Show more...

Investment focus

  • Medical, mHealth, Health Care
  • Series A
  • Finland

Portfolio highlights

  • Kaiku Health — Kaiku Health is a digital health company with a mission to improve quality of life through health data science. We have built an intelligent digital platform for monitoring patient-reported outcomes in several therapy areas, such as cancer care, fertility treatments and preventive health care. Its unique algorithms enable early interventions andpersonalized patient support. Currently over 30 European hospitals and clinics are using our platform to better monitor their patients, reducing manual work and allowing prioritization of clinical actions. This along with the capture and analysis of real-world data paves way for more personalized and effective care of each patient. The company, founded in 2012 by five software developers deeply passionate about health care technology, has now grown to team of 20+ dedicated employees. The company is backed by Reaktor Ventures, along with other venture capital funds and private investors, and is supported by Tekes – the Finnish Funding Agency for Innovation.
  • Synoste Oy — Patient friendly and innovative solutions for correcting skeletal deformations.
Show more investments...

Vesalius Biocapital Partners
VC Fund · Strassen, Luxembourg, Luxembourg · 1 investment in the past 12 months

Vesalius Biocapital Partners invests in companies active in human health through venture capital funds raised since 2007. They have contributed to developing 20 companies since inception.With more than € 150 million under management in two funds. Vesalius Biocapital Partners plays the role of lead investor in the large majority of its financingrounds.Their companies are based in Europe allowing easy interaction with management.They invest in all stages of development and do not shy away from relatively early-stage projects with a sound proprietary technology and corresponding IP, unique team skills and a clear competitive edge based on solid data.

Show more...

Investment focus

  • Biotechnology, Health Care, Medical
  • Series B, Series A, Series C
  • Belgium, Germany, The Netherlands

Portfolio highlights

  • CatalYm — Catalym develops antibodies against a placental factor which is overexpressed by various tumour types.
  • Scenic Biotech — We are pioneers in the discovery of genetic modifiers to enable the development of transformative therapeutics.
  • Memo Therapeutics — Memo Therapeutics AG (MEMO) is an innovator in the field of antibody discovery and immune repertoire analysis.Its MemoMAB™ platform creates a recombinant in vitro copy of an individual’s B cell / antibody repertoire, which is then banked as a library. The resulting unique, large and relevant antibody libraries represent the individual’simmune repertoire and are expected to contain an unprecedented number of relevant and rare antibodies. This leads to entirely new possibilities in immune repertoire analysis and antibody discovery.MemoMAB™ is deployed in proprietary antibody lead discovery programs and is made available in collaborations.
Show more investments...

Novo Holdings
VC Fund · Hellerup, Hovedstaden, Denmark · 19 investments in the past 12 months

Novo Holdings is a world-leading life science investor with a focus on creating long-term value.

Show more...

Investment focus

  • Biotechnology, Health Care, Medical
  • Series A, Series B, Series C
  • United States, Denmark, United Kingdom

Portfolio highlights

  • AMSilk — AMSilk produces and distributes high-quality silk biopolymers for use in textile products, medical devices, and cosmetics.
  • Octave — Octave is a national behavioral health practice that’s creating a new standard for care delivery that’s both high-quality and accessible to more people. With in-person and virtual clinics in California and New York, the company offers personalized care plans that can include individual therapy, couples therapy, and groups, while pioneeringrelationships with payers to make care more affordable through insurance. Grounded in science, Octave enables clients to experience profound change that is as measurable as it is meaningful.
  • Alentis Therapeutics — Alentis Therapeutics discovers and develops novel medications to treat advanced liver diseases.
Show more investments...

Maki.vc
VC Fund · Helsinki, Southern Finland, Finland · 6 investments in the past 12 months

Maki.vc is an early-stage venture capital firm partnering with deep tech & brand-driven startups obsessed with challenging category norms.

Show more...

Investment focus

  • Software, SaaS, E-Commerce
  • Seed, Series A, Funding Round
  • Finland, Germany, United Kingdom

Portfolio highlights

  • Strise — Strise is signaling a new era of enterprise software and organizational change, transforming how companies work and empowering individual growth through knowledge. We believe in the AI-enabled financial institution without data silos where users and data are working together to solve even the most complex business problems.
  • Databutton — Databutton is an online app builder that empowers the next generation of entrepreneurs and innovators. It enables anyone to create dynamic online apps in minutes by connecting to a growing array of sources, models, and integrations, or by utilizing their own datasets. 먹튀검증 https://muktts.net/
  • Quanscient — We are building next generation simulation software-as-a-service utilizing Quantum computing algorithms. Our specialty domain of simulations is Computational Electromagnetics.
Show more investments...

Inventure
VC Fund · Helsinki, Southern Finland, Finland · 6 investments in the past 12 months

Since 2005, Inventure has backed over 90 companies including Wolt, Swappie, Jobbatical, aiMotive, and more.

Show more...

Investment focus

  • Software, Information Technology, Health Care
  • Seed, Series A, Funding Round
  • Finland, Sweden, Denmark

Portfolio highlights

  • Haltian — End-to-end IoT solutions and world-glass product design services from Haltian
  • Commsignia — Commsignia specializes in the research and development, manufacturing and distribution of cooperative intelligent transportation systems. Its product line includes a V2X Communication Software Stack and Commsignia’s own security stack implementation, Hybrid V2X/ADAS Safety Applications, a V2X Simulator, On-Board Units (OBU) and Roadside Units(RSU).The company was founded in 2012 and is headquartered in Santa Clara, California.
  • Value.Space — Space based risk assessments & monitoring
Show more investments...

Hadean Ventures
VC Fund · Oslo, Oslo, Norway

Hadean Ventures is a life science fund manager that invests in life science companies across europe with a particular focus on the nordic region. The funds are backed by leading private and institutional investors. Hadean Ventures has offices in oslo and stockholm and collaborates with world-class academic institutions and start-up hubs across theregion

Show more...

Investment focus

  • Biotechnology, Health Care, Pharmaceutical
  • Series A, Funding Round, Series B
  • Sweden, Norway, Austria

Portfolio highlights

  • Ribbon Biolabs — Ribbon Biolabs revolutionary technology for the fast and efficient automated synthesis of DNA is here to enable the new wave of biotechnological innovation.
  • Alex Therapeutics — The Alex DTx Platform enables partners within pharma and health care to effectively and reliably launch new DTx treatments by leveraging existing insights, modules, processes and data.
  • TargED Biopharmaceuticals — TargED Biopharmaceuticals is a biotechnology company that develops first-in-class biological drugs to improve treatment of thrombosis.TargED stands for Targeted Enzyme Delivery. Their biological drugs are unique by using small antibodies (“VhH”) to deliver enzymes to sites of thrombosis, enabling ‘targeted’ thrombolysis.
Show more investments...

Way to Wellville
VC Fund · Astoria, Oregon, United States

Wellville is a 10-year national nonprofit project to achieve equitable wellbeing. We support the efforts of The Wellville 5: Five US communities.

Show more...

Investment focus

  • Software, Health Care, Medical
  • Funding Round, Series B, Series A
  • United States, Finland

Portfolio highlights

  • Upbeat — Upbeat is a software-powered next-generation PR agency that focuses on media marketing for various companies. The company is a team of software engineers and PR professionals working together to bring the old-school PR industry to the modern world. Upbeat turns story ideas to into something presentable by connecting the best stories to the beststorytellers. They also manage email outreach and follow-ups and keep track of pitch's progress with real-time analytics and email updates. And, its software is also an avenue to monitor media opportunities on company's behalf.
  • Trimian — Startup based in Menlo Park, focusing on mobile apps. The name comes from 'tri-simian', referring to the three wise monkeys.
  • Big Health — Our mission is to help millions back to good mental health. Our digital therapeutics are safe and effective non-drug alternatives for mental health.
Show more investments...

Inveni Capital
VC Fund · Helsinki, Southern Finland, Finland

Inveni Capital is a venture capital management company focused on investments in early to growth stage life sciences companies.

Show more...

Investment focus

  • Medical, Health Care, Biotechnology
  • Funding Round
  • Finland, United Kingdom

Portfolio highlights

  • BioSilta — BioSilta Ltd. is a privately-held company that utilizes its unique, proprietary EnBase® technology platform to develop innovative, reagent-based EnPresso® growth systems. When compared to conventional growth media, EnPresso growth systems significantly increase the yield of high quality biomolecules from microbial cultures.
  • Onbone — Onbone Ltd is a Finnish innovative company working on the field of medical technology. The company develops and markets innovative and user-friendly Woodcast products for orthopaedic and traumatology use. Onbone Ltd has eleven employees and the products are sold in Finland, Germany, Sweden, Holland and Great Britain.
Show more investments...

Capricorn Partners
VC Fund · Leuven, Vlaams-Brabant, Belgium · 7 investments in the past 12 months

Capricorn Partners is a unique independent manager of venture capital, growth capital and quoted equity funds

Show more...

Investment focus

  • Biotechnology, Health Care, Software
  • Funding Round, Series B, Series A
  • Belgium, United States, The Netherlands

Portfolio highlights

  • Chainels — The tenant experience app for every property in your portfolio. Save time, gain insights and collaborate with your tenants all in one place.
  • VoxelSensors — Novel sensor architecture designed for low latency and low power 3D perception.
  • fruitcore robotics — fruitcore robotics is a robotic system that leverages intelligent software and innovative mechatronics.
Show more investments...

Sunstone Life Science Ventures
VC Fund · Copenhagen, Hovedstaden, Denmark · 2 investments in the past 12 months

Sunstone Life Science Ventures is an independent European venture capital investment firm. We enable and empower life science therapeutics innovations.

Show more...

Investment focus

  • Biotechnology, Health Care, Medical
  • Funding Round, Series B, Series A
  • Denmark, Sweden, Switzerland

Portfolio highlights

  • Teitur Trophics — Teitur Trophics is a biotech company developing circular peptides for neurodegenerative diseases. The company was founded in 2020 and is headquartered in Aarhus, Denmark.
  • Rewind Therapeutics — Rewind Therapeutics is a developer of novel therapeutics intended to facilitate the treatment for neurological diseases.The company's first-in-class remyelinating therapeutics block inhibitory signals that prevent the expansion and migration of oligodendrocyte stem cells in order to promote effective remyelination, enabling medicalpractitioners to treat patients suffering from multiple sclerosis and other myelin-related diseases with efficacy.
  • TargED Biopharmaceuticals — TargED Biopharmaceuticals is a biotechnology company that develops first-in-class biological drugs to improve treatment of thrombosis.TargED stands for Targeted Enzyme Delivery. Their biological drugs are unique by using small antibodies (“VhH”) to deliver enzymes to sites of thrombosis, enabling ‘targeted’ thrombolysis.
Show more investments...

MVM Life Science Partners
VC Fund · London, England, United Kingdom · 1 investment in the past 12 months

MVM invests in innovative healthcare companies. Our active portfolio companies are transforming the delivery of healthcare by enabling higher quality, cost-effective care in large, global markets.

Show more...

Investment focus

  • Biotechnology, Health Care, Medical
  • Funding Round, Series B, Series A
  • United States, United Kingdom, Germany

Portfolio highlights

  • Ossio — OSSIO is an orthopedic fixation company committed to transforming the orthopedic experience for patients, physicians, and payors. Their vision is to provide the first credible replacement to metal implants in the $10B+ orthopedic fixation market (screws, pins, plates) with an Intelligent Bone Regeneration Technology. OSSIOfiber represents abreakthrough material platform for orthopedic and podiatric surgeons who seek a more biologically friendly way to restore patient stability and mobility with nothing permanent left behind.Founded in 2014, OSSIO began as the culmination of years of biomechanical research and a vision for the possibility of better bone healing. The technological basis of OSSIOfiber™ was developed and would lay the groundwork for ushering in a new breakthrough category of non-permanent fixation, “Bio-Integratives” hardware that has both desired strength AND bio-friendliness. Hardware that has the mechanical strength for easy insertion and secure fixation, while enabling the body to regrow bone, incorporating and replacing the implant (without the adverse inflammation and weakness often seen in “bio-resorbables and other “bio-composites”), has remained elusive to the industry until now.
  • Nalu Medical — Nalu Medical is an early-stage company that develops a range of medical devices. Their vision to modernize and improve the technology in medical devices, thus improving the lives of people.The Nalu neurostimulation system is a battery-free, micro-implantable pulse generator (iPG) currently cleared by the FDA for both Spinal Cord Stimulation (SCS)and Peripheral Nerve Stimulation (PNS) for mitigating chronic pain. The company was founded in 2014 and is based in Carlsbad, California.
  • Neurolens — 2/3 of patients experience the symptoms of eye misalignment, but relief is in sight with Neurolens using the NMD2 and Neurolenses with Contoured Prism.
Show more investments...

Cor Group
VC Fund · Oulu, Oulu, Finland

Cor Group management consulting firm serving Psychological, Educational, and Behavioral Services.

Show more...

Investment focus

  • Health Care, Medical, Biotechnology
  • Seed, Pre-Seed, Series A
  • Finland

Portfolio highlights

  • Adamant Health — Adamant Health’s unique technology to analyse Parkinson’s disease symptoms is based on over 15 years of academic research at the University of Eastern Finland. With the technology, clinicians have several days detailed visibility to the patient’s symptoms and is able to optimise the treatment accordingly. Pharma companies benefit from the objectiveand long-term RW data in their clinical and post market studies and can utilise it as complementary diagnostics tool for personalised medication.
  • Nightingale Health — Driving the shift from reactive to preventative care with innovative solutions that enable early detection and proactive management of health risks.
Show more investments...

High-Tech Grunderfonds
VC Fund · Bonn, Nordrhein-Westfalen, Germany · 64 investments in the past 12 months

High-Tech Gründerfonds (HTGF) is a seed investor that finances high-potential, tech-driven startups. With EUR 895.5 million in total investment volume across three funds and an international network of partners, HTGF has already helped forge more than 500 startups since 2005. Driven by their expertise, entrepreneurial spirit, and passion, its teamof experienced investment managers and startup experts help guide the development of young companies. HTGF’s focus is on high-tech startups in a range of sectors, including software, media, internet, hardware, automation, health care, chemistry, and life sciences.To date, external investors have injected over EUR 2 billion into the HTGF portfolio via about 1,400 follow-on financing rounds. HTGF has also successfully sold interests in more than 100 companies. Investors in this public-private partnership include the Federal Ministry For Economic Affairs and Energy, the KfW Banking Group, and Fraunhofer-Gesellschaft e.V., as well as the companies ALTANA, BASF, BAYER, B.Braun, Boehringer Ingelheim, Robert Bosch, BÜFA, CEWE, Deutsche Post DHL, Dräger, Drillisch AG, EVONIK, EWE AG, FOND OF Haniel, Hettich, Knauf, Körber, LANXESS, media + more venture Beteiligungs GmbH & Co. KG, PHOENIX CONTACT, Postbank, QIAGEN, RWE Generation SE, SAP, Schufa, Schwarz Gruppe, STIHL, Thüga, Vector Informatik, WACKER and Wilh. Werhahn KG.

Show more...

Investment focus

  • Software, Information Technology, Biotechnology
  • Seed, Series A, Funding Round
  • Germany, Switzerland, United States

Portfolio highlights

  • Inovedis — Inovedis offers innovative solutions in medical technology that contribute both to optimized patient care as well as time and cost reductions in the healthcare sector.
  • Resourcify — Mein Recycling is developed by Resourcify GmbH from Hamburg. The app is the easiest solution for businesses to easily manage all of their waste, collections, and recyclers in one app, and for waste management companies to seamlessly connect with their customers online. Their vision is zero-waste: enabled with the digital transformation of the wastesector as the foundation for the circular economy.
  • traceless materials — traceless materials offer a holistically sustainable alternative to plastics: 100% biobased on plant residues, compostable under natural conditions, and free of toxic chemicals. For a future free of pollution and waste!
Show more investments...

M Ventures
VC Fund · Amsterdam, Noord-Holland, The Netherlands · 17 investments in the past 12 months

Merck Ventures is the strategic, corporate venture capital arm of Merck. Its mandate is to invest in innovative technologies and products with the potential to significantly impact Merck‘s core business areas. From its headquarters in Amsterdam and offices in the US and Israel we invest globally in transformational ideas driven by greatentrepreneurs. Merck Ventures takes an active role in its portfolio companies and teams up with entrepreneurs and co-investors to translate innovation towards commercial success. Merck Ventures has a significant focus on early-stage investing and company creation including the creation of spin-offs to leverage Merck‘s science and technology base.

Show more...

Investment focus

  • Biotechnology, Health Care, Therapeutics
  • Series A, Series B, Seed
  • United States, Switzerland, United Kingdom

Portfolio highlights

  • CellFE — CellFE is a company developing a microfluidics based device to deliver gene-editing molecules. CellFE developed microfluidic device and process that can efficiently deliver gene-editing molecules into the human cells.
  • BeeOLED — BeeOLED’s technology enables OLED displays with significantly improved efficiency, brightness and operational stability at lower overall costs due to a less complex device structure.
  • Lightcast Discovery — Flexible control over droplet number, occupancy, location and movement. Enabling efficient, multi-step workflows with unprecedented flexibility.
Show more investments...

Novartis Venture Fund
VC Fund · Basel, Basel-Stadt, Switzerland · 5 investments in the past 12 months

Our primary focus is on the development of novel therapeutics and platforms. We balance the therapeutic focus with investments in medical devices, diagnostics or drug delivery systems. In our investments we look for unmet need and clinical impact, novel proprietary science and understanding of mechanism, management and board experience and capitalefficiency in the program.We prefer to have our initial investment at the early stage to build the company and follow with additional investment in pace with the company:tm:s progress. We continue our approach of larger focused investments and anticipate total investments up to USD 30 to 50 mio per company over its life, but it can be as little as 100'000 USD to get started. We will increase our activities to lead or co-lead deals further and remain open to participate in larger syndicates. SectorsNew therapeutics & platformsMedical devices/implantsDiagnostics/biomarkersDrug delivery/biopolymersGeographyUSA/CanadaEuropeSwitzerlandAsia/Pacific

Show more...

Investment focus

  • Biotechnology, Health Care, Therapeutics
  • Series B, Series A, Series C
  • United States, Switzerland, United Kingdom

Portfolio highlights

  • Hyku — Hyku Biosciences is developing the next generation of covalent medicines by targeting histidine, tyrosine and lysine binding pockets in disease-causing proteins.
  • Hepalink — Hepalink is a manufactures ultra-pure pipeline control systems based on semiconductors and pan-semiconductor liquid circuits.
  • Mediar Therapeutics — Mediar Therapeutics is a preclinical stage biotechnology company developing antibody-based therapeutics to halt fibrosis in a variety of organ systems, including lung, liver, kidney, and skin.
Show more investments...

Tesi
VC Fund · Helsinki, Southern Finland, Finland · 10 investments in the past 12 months

Finnish Industry Investment Ltd is a government-owned investment company. It invests the proceeds accrued from the privatisation of state-owned companies in stimulating the growth and internationalisation of Finnish businesses.Finnish Industry Investment invests in venture capital funds and directly in growth companies, together with privateco-investors. The targets are in all sectors. Capital investments are needed for financing the growth of investee companies, and for spin-offs, major industrial investments, and sector and corporate restructurings.The investments of Finnish Industry Investment amount to over MEUR 570

Show more...

Investment focus

  • Software, Manufacturing, Health Care
  • Funding Round, Series A, Series B
  • Finland, United States, Argentina

Portfolio highlights

  • Virta — The Virta platform for electric vehicle charging gives you an accelerated and cost-effective channel to launch, operate, and grow an EV charging business.
  • Measurlabs — We provide testing services for any material, product, or chemical, helping product developers and quality managers get the information they need about their products.
  • Algorithmiq — Algorithmiq utilizes its expertise in quantum information, complex systems, and computational physics to develop algorithms to develop new and effective drugs, solve problems in life sciences, and discover new materials.
Show more investments...

Springvest
VC Fund

Investment focus

  • Biotechnology, Health Care, Energy
  • Series A, Funding Round
  • Finland

Portfolio highlights

  • Convion — Convion is a fuel cell system developer committed to commercializing solid oxide fuel cell systems in range of 50–300kW for distributed power generation. The company's products are designed for premium energy efficiency, reliability, and operational flexibility. Convion will provide its customers with sustainable power generation solutions forpower security, energy independence, and premium efficiency.Convion was founded 2012 and is based in Finland.
  • Mobidiag — Mobidiag is a commercial stage, fast-growing Finnish-French biotechnology company that develops and markets innovative molecular diagnostic solutions for gastrointestinal infections, antimicrobial resistance management, healthcare associated infections (HAIs), respiratory infections and sepsis. Based on well-established qPCR and microarraytechnologies, Mobidiag offers a broad range of tests and automated platforms. These include a comprehensive range of fast, reliable and cost-effective molecular diagnostic solutions for the detection of infectious diseases adapted to laboratories of all sizes. They allow detection of most clinically relevant bacteria, parasites, viruses and markers for antibiotic resistance.
  • Finbiosoft — Finbiosoft is a company focused in developing Validation Manager™ software service. Validation Manager is the perfect tool for clinical laboratories and diagnostic companies to digitalize, automate and standardize the time-consuming and error sensitive data handling of validations and verifications.
Show more investments...

Nuard Ventures
VC Fund

Nuard Ventures invests in innovative early stage companies.

Show more...

Investment focus

  • IaaS, Real Time, Predictive Analytics
  • Seed, Funding Round
  • Finland, Germany, United States

Portfolio highlights

  • WARD — WARD is a fantasy sport game, where fans can watch their favourite eSports matches and predict what will happen in real time.WARD is a startup out of Berlin which has created a “pick and predict” real-time prediction smartphone game, where players can win real prizes. People love to watch e-sports. We believe on these occasions they still want tobe able to participate.However, until now no product has offered anything other than the ability to watch. There’s been no way for fans to spectate, participate, analyse and predict the outcomes of their favourite games.
  • MVision AI — MVision develops technology that improves the treatment of various types of cancer by using artificial intelligence and machine learning. The company has been built on the idea to be an impactful organisation by bringing AI assisted diagnosis and treatment to whoever needs it, especially in developing countries. This dramatically improves treatmentoutcome and saves money.The founding team consists of AI PhD’s, data platform architects and physicists with experience from companies such as Varian Medical Systems and GE healthcare.
  • Polka Dot Studio — PolkaDot, based in Helsinki, Finland, is a female led mobile games studio that creates fashion and lifestyle games for women. This is highly underserved audience with big spending potential and demand for new experiences. Our first game is a social mobile game where female players can interact with the brands they know, and influencers theyidolize, through fashion, in a fun and rewarding way.
Show more investments...

Metaplanet Holdings
VC Fund · Tallinn, Harjumaa, Estonia · 12 investments in the past 12 months

an early-stage investment firm making long-term bets on contrarians and leveraging the knowledge and network across sectors. We back mission-driven founders working on positively disruptive deep technologies.

Show more...

Investment focus

  • Artificial Intelligence, Software, Machine Learning
  • Seed, Series A, Series B
  • United States, United Kingdom, Estonia

Portfolio highlights

  • Fhenix — End-to-End Encrypted Web3 Fhenix is the first blockchain powered by fully homomorphic encryption to bring Computation Over Encrypted Data to EVM smart contracts Join us Learn more A new, encrypted web is waiting for you Truly functional markets require end-to-end encryption. Fhenix rises to the challenge by unlocking unprecedented encryption capabilities in the public blockchain
  • SiPhox Health — SiPhox offers a handheld testing device with RNA/DNA and protein testing for point-of-care and At-Home solutions. The company's kit is made by multiplexing RNA, antibody, and antigen tests on a single silicon photonic chip which is amplified by plasmon resonance and silicon photonic resonator readout, enabling users to undertake tests fordisease safely and in a disposable point-of-care and at-home manner.SiPhox was founded in 2020 and is based in Cambridge, Massachusetts, USA.
  • Cognaize — Cognaize, an Intelligent Document Processing company, automates unstructured data with hybrid intelligence. Our data-centric AI platform facilitates meaningful cooperation of AI and humans.
Show more investments...

Noaber
VC Fund · Lunteren, Gelderland, The Netherlands · 1 investment in the past 12 months

Noaber Ventures invests in initiatives that bring social transformations using information technology.

Show more...

Investment focus

  • Health Care, Medical, Fitness
  • Seed, Series A, Funding Round
  • The Netherlands, Israel, Sweden

Portfolio highlights

  • Newsenselab (M-sense) — M-sense is a certified medical app to combat migraines and headache. Our goal is to reduce 50% of headache days through a personalized therapy program - all in-app.
  • Elsa — Elsa is a platform for patient driven research for better drugs, health and prevention. Elsa lets patients become their own personal researchers by providing them with a better understanding around how lifestyle factors may affect their disease activity measurements for chronic disease. To support them from a scientific perspective, Elsa gives themaccess to data on their specific disease (initially we work with rheumatoid arthritis) through the Riskminder foundation and scientific studies at Karolinska Institutet.
  • Alba Health — Discover your baby's gut health & microbiome for the best start in life.
Show more investments...

Visionplus
VC Fund · Helsinki, Southern Finland, Finland · 1 investment in the past 12 months

WE HELP YOU TO GROW FASTER!

Show more...

Investment focus

  • Software, Information Technology, Internet
  • Seed, Funding Round, Series A
  • Finland, United States, United Kingdom

Portfolio highlights

  • Pebble — Pebble is a electric vehicle manufacturing startup.
  • Transfluent — Professional translations for all business needs. Fast. Easy.
  • BetterDoctor — BetterDoctor helps validate and deliver accurate provider data to health plans, health systems, and hundreds of other companies via its API — from startups to publicly traded ones. This ultimately helps achieve the mission of helping consumers find the healthcare they need.Today, BetterDoctor's data platform and APIs power 9 health plans,350 companies, 1,500 developers, helping millions of people find the right doctor each month. Health Plans BetterDoctor uses multi-modal outreach to drive providers to attest their information on BetterDoctor's online portal. API PartnersBetterDoctor brings transparency to doctor data. Their real-time platform, master database and API services enable everyone to add doctor data to their systems, websites and applications. Today, BetterDoctor API and data tools power health insurance companies, healthcare startups and doctor search tools. https://betterdoctor.com/developers
Show more investments...

SHS Capital
VC Fund · Tübingen, Baden-Wurttemberg, Germany · 2 investments in the past 12 months

SHS, founded in 1993, is an independent private equity company. Their focus is on investments in the MedTech, Life Sciences, Diagnostics and Digital Health sectors.SHS is one of the leading healthcare growth investors in Germany and has launched five generations of funds since its foundation and invested in over 50 companies. Investments arecurrently being made by the fourth and fifth generations of funds. The latest fund, SHS V, is still open for subscription until end of June 2019.They do invest in young, high-growth companies as well as realize small buyouts and growth financings of established companies.

Show more...

Investment focus

  • Health Care, Medical Device, Biotechnology
  • Funding Round, Series C, Series A
  • Germany, Switzerland, France

Portfolio highlights

  • MESI Medical — The MESI mTABLET provides predictive medical assessment with a wide selection of hardware modules, software extensions and different integration options.
  • Dr.Dropin — Dr.Dropin an accessible and modern private health service that offers the vast majority of medical services at a fixed price.
  • Simulands — Simulands improve patient outcomes through simulation-based medical training. Simulands solutions are more practical, cost effective, and ethical versus traditional methods.
Show more investments...

Debiopharm Innovation Fund
VC Fund · Lausanne, Vaud, Switzerland · 3 investments in the past 12 months

Debiopharm invests in Smart Data & Digital Health companies developing technologies that are applicable in the areas of oncology or infectious diseases

Show more...

Investment focus

  • Health Care, Biotechnology, Medical Device
  • Series A, Series B, Series C
  • Switzerland, United States, France

Portfolio highlights

  • Iktos — Iktos is the only company to offer generative modeling with built-in synthetic accessibility for successful drug discovery
  • Yonalink — EHR-to-EDC Data Streaming Bridging the Gap Between Patient Care and Clinical Research LEADER IN INTEROPERABILITY Yonalink provides the missing link in clinical trials with technology that is purpose-built to stream and map up-to-date data, securely automating the transfer of patient data from EHRs to EDCs. Our SaaS solution is bringing new levels of speed, quality, and
  • Altis Labs — Altis Labs is the computational imaging company advancing precision medicine. We believe that medical imaging is the richest source of untapped information. Life sciences companies use our software platform, Nota, to accelerate all stages of clinical development. Trained on over 140 million longitudinal real-world images with associated clinicalinformation, our deep learning models predict clinically meaningful outcomes to quantify treatment effect more accurately.
Show more investments...

Athensmed
VC Fund

Athensmed Oy

Show more...

Investment focus

  • Health Care, Medical, mHealth
  • Seed, Series A, Funding Round
  • Finland

Portfolio highlights

  • Kaiku Health — Kaiku Health is a digital health company with a mission to improve quality of life through health data science. We have built an intelligent digital platform for monitoring patient-reported outcomes in several therapy areas, such as cancer care, fertility treatments and preventive health care. Its unique algorithms enable early interventions andpersonalized patient support. Currently over 30 European hospitals and clinics are using our platform to better monitor their patients, reducing manual work and allowing prioritization of clinical actions. This along with the capture and analysis of real-world data paves way for more personalized and effective care of each patient. The company, founded in 2012 by five software developers deeply passionate about health care technology, has now grown to team of 20+ dedicated employees. The company is backed by Reaktor Ventures, along with other venture capital funds and private investors, and is supported by Tekes – the Finnish Funding Agency for Innovation.
  • VideoVisit — Oiva Health on digipalveluiden asiantuntijayritys, joka palvelee kattavasti sosiaali- ja terveysalan toimijoita.
  • Finnadvance — Finnadvance is an Organ-On-Chip company developing high throughput biological barriers on chips to mimic human biology such as vascular, lung and the Blood-Brain-Barriers for small molecule, micro-nano-formulation permeability and toxicity testing with in-vivo like dynamic cell cultures.
Show more investments...

Ascend Capital Partners
VC Fund · Hong Kong, Hong Kong Island, Hong Kong · 1 investment in the past 12 months

Founded by two Wall Street professionals in 2002 with the goal of making companies successful by helping them raise capital and improve their management standards. This was done by taking an active role in running these companies (at the Board level and operationally) and helping to secure strategic partnerships.Over USD 100 million in assetsgenerated from successful investments in China, and more recently in Europe. All invested funds come from our partners; no 3rd party money is managed. Since the partners are investing their own capital, they are dedicated to making their investments successful.Led by Monita Mo, one of the founders and a serial entrepreneur. Our partners have decades of experience across a wide range of industries and geographical regions. All investment partners have done business in Asia and bring an extensive network of contacts for our investments. Additionally, they have started, managed, and sold businesses and understand the challenges involved.See the need to share more developed technology to other markets, especially in China, where growth opportunities may be greater. That is why we are currently focusing on companies in Europe and other developed markets that have unique technologies that can be commercialized in their home markets, Asia, and the US.

Show more...

Investment focus

  • Health Care, Medical Device, Automotive
  • Series A, Seed, Funding Round
  • Finland, United States, Canada

Portfolio highlights

  • Battlesnake — Controlled by a web server you build, and the code you write, Battlesnakes move to find food, avoid others, and stay alive.
  • Inflection.io — Marketing technology for product-led companies
  • Nanoflex Robotics — Nanoflex Robotics develops a soft robotic system that precisely inserts specially made guidewires and catheters deep into the brain. The company provides patented magnetic navigation technology but also the necessary surgical devices. Nanoflex Robotics was established in May, 2021 in Zurich, Switzerland.
Show more investments...

Cascara Ventures
VC Fund · Brussels, Brussels Hoofdstedelijk Gewest, Belgium

96 Normal 0 false false false EN-GB X-NONE X-NONE

Show more...

Investment focus

  • Medical, Health Care, Biotechnology
  • Series A, Seed, Series B
  • Germany, Finland, The Netherlands

Portfolio highlights

  • Surgify — Surgify are currently preparing the commercialization of a novel technology for bone surgery at Aalto University with financial support from Tekes (Finnish Funding Agency for Innovation). To enable continuous communication with clinicians, they have been working in close cooperation with Neurosurgical Department of Helsinki University CentralHospital, part of HUS (The Hospital District of Helsinki and Uusimaa).
  • ATRO Medical — ATRO Medical is a spin-out from DSM and Radboudumc and builds on the knowledge developed in the Public-Private Collaboration BioMedical Materials that started in 2010 with a consortium of universities, private companies, and financial support from the Dutch government. The collaboration between the clinical, biomechanical, and polymer expertise hascreated the base for the Trammpolin design and the development towards a prototype.
  • microDimensions — microDimensions provides digital pathology software and services: image analysis, 3D histology reconstruction, protein multiplexing, stereology, image registration.
Show more investments...
Investors by industry
Investors by country
VC (Venture Capital) Funds in Finland by industry

Close your round

Find who invests in your industry, stage, and region in our 200k+ database with AI-powered matching.

Find investors — It's Free!

Join 21,000+ founders from:

Y Combinator Techstars Antler Pioneer On Deck